Human bancroftian filariasis: immunological markers of morbidity and infection

Microbes and Infection

Volumn 8, Issue 9-10, 2006, Pages 2414-2423

  Satapathy, Ashok K ^a   Sartono, Erliyani ^b   Sahoo, Prakash K ^a   Dentener, Mieke A ^c   Michael, Edwin ^d   Yazdanbakhsh, Maria ^b   Ravindran, Balachandran ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Filariasis; Morbidity markers; TNF receptors; TNF ; Wuchereria bancrofti

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN; PROTEIN LBP; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MARKER; ENDEMIC DISEASE; FEMALE; FILARIASIS; GENETIC POLYMORPHISM; HOST RESISTANCE; HUMAN; IMMUNOASSAY; IMMUNOGENETICS; IMMUNOPATHOGENESIS; INDIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CHILD; CYTOKINES; ELEPHANTIASIS, FILARIAL; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MORBIDITY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA; WUCHERERIA BANCROFTI;

WUCHERERIA BANCROFTI;

EID: 33749351475     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.05.003     Document Type: Article

References (38)

1. Kumaraswami V. Lymphatic Filariasis. In: Nutman T.B. (Ed) (2000), Imperical College Press, London 103-126
2. Sahoo P.K., Babu Geddam J.J., Satapathy A.K., Mohanty M.C., and Ravindran B. Bancroftian filariasis: prevalence of antigenaemia and endemic controls in Orissa, India. Trans. R. Soc. Trop. Med. Hyg. 94 (2000) 515-517
3. Ravindran B., Satapathy A.K., Sahoo P.K., and Babu Geddam J.J. Protective immunity in human bancroftian filariasis: inverse relationship between antibodies to microfilarial sheath and circulating filarial antigens. Parasite Immunol. 22 (2000) 633-637
4. Pani S.P., Yuvaraj J., Vanamali P., Dhanda V., Michael E., Grenfell B.T., and Bundy D.A. Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 89 (1995) 72-74
5. Lammie P.J., High tower A.W., and Eberhard M.L. Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. Am. J. Trop. Med. Hyg. 51 (1994) 348-355
6. Ravindran B. Are inflammation and immunological hyperactivity needed for filarial parasite development?. Trends Parasitol. 17 (2002) 70-73
7. Das B.K., Mishra S., Padhi P.K., Manish R., Tripathy R., Sahoo P.K., and Ravindran B. Pentoxyifylline adjunct improves prognosis of cerebral malaria in adults. Trop. Med. Int. Health 8 (2003) 680-684
8. Kwiatkowski D., Molyneux M.E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D.R., and Grau G.E. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 86 (1993) 91-98
9. Titus R.G., Sherry B., and Cerami A. The involvement of TNF, IL-1 and IL-6 in immune response to protozoan parasites. Immunol. Today 12 (1991) A13-A16
10. Das B.K., Sahoo P.K., and Ravindran B. A role for tumor necrosis factor-α in acute lymphatic filariasis. Parasite Immunol. 18 (1996) 421-424
11. Taylor M.J., Cross H.F., and Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J. Exp. Med. 17 (2000) 1429-1436
12. Taylor M.J., and Hoerauf A. Wolbachia bacteria of filarial nematodes. Parasitol. Today 15 (1999) 437-442
13. Van Deuren M. Kinetics of tumor necrosis factor-alpha, soluble tumor necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur. J. Clin. Microbiol. Infect. Dis. 13 (1994) S12-S16
14. Zijlstra E.E., Van der Poll T., and Mevissen M. Soluble receptors for tumor necrosis factor markers of disease activity in visceral leishmaniasis. J. Infect. Dis. 171 (1995) 498-501
15. Kawaguchi H., Ina Y., Ito S., Sato S., Sugiura Y., Tomita H., Ogisu N., Takada K., Yamamoto M., Morishita M., and Yoshikawa K. Serum levels of soluble tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis. Kekkaku 71 (1996) 259-265
16. Godfried M.H., Romijn J.A., Van der Poll T., Weverling G.J., Corssmit E.P.M., Endert E., Schattenkerk J.K.E., and Sauerwein H.P. Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism 44 (1995) 1564-1569
17. Day N.P.J., Hien T.T., Schollaardt T., Phu Loc P., Chuong L.V., Hong Chau T.T., Hoang Mai N.T., Hoan Phu N., Xuan Sinh D., White N.J., and Ho M. The prognostic and pathophysiologic role of pro and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180 (1999) 1288-1297
18. Mwatha J.K., Kimani G., Mbugua G.G., Ouma J.H., Mumo J., Fulford A.J.C., Jones F.M., Butterworth A.E., Roberts M.B., and Dunne D.W. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human Schistosomiasis Mansoni. J. Immunol. 160 (1998) 1992-1999
19. Barrera P., J Haagsma C., Boerbooms A.M.Th., M Van Riel P.L.C., Borm G.F., Van De Putte L.B.A., and Van Der Meer J.W. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists: longitudinal evaluation in patients with rheumatoid arthritis. Br. J. Rheumatol. 34 (1995) 747-755
20. Haarbrink M., Abadi G.K., Buurman W.A., Dentener M.A., Terhell A.J., and Yazdanbakhsh M. Strong association of interleukin-6 and lipopolysaccharide-binding protein with severity of adverse reactions after diethylcarbamazine treatment of microfilaraemic patients. J. Infect. Dis. 182 (2000) 564-569
21. Haarbrink M., Terhell A.J., Abadi G.K., Mitsui Y., and Yazdanbakhsh M. Inflammatory cytokines following diethylcarbamazine (DEC) treatment of different clinical groups in lymphatic filariasis. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 665-672
22. Froon A.H., Bonten M.J., Gaillard C.A., Greve J.W., Dentener M.A., de Leeuw P.W., Drent M., Stobberingh E.E., and Buurman W.A. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am. J. Respir. Crit. Care Med. 158 (1998) 1026-1031
23. Scheiner S.M. MANOVA: multiple response variables and multispecies interactions. In: Scheiner S.M., and Gurevitch J. (Eds). In Design and Analysis of Ecological Experiments (2001), Oxford University Press, Oxford 99-115
24. Harris R.J. A Primer of Multivariate Statistics (1985), Academic Press, New York
25. Efron B., and Tibshirani R. Statistical data analysis in the computer age. Science 253 (1991) 390-395
26. Ottesen E.A. Infection and disease in lymphatic filariasis: an immunological perspective. Parasitology 104 (1992) S71-S79
27. Stenvinkel P., Lindholm B., Heimburger M., and Heimburger O. Elevated serum levels of soluble adhesion molecules predict death in patients: association with malnutrition, inflammation, and cardiovascular disease. Nephrol. Dial. Transplant. 15 (2000) 1624-1630
28. Hack C.E., Aarden L.A., and Thijs L.G. Role of cytokines in sepsis. Adv. Immunol. 66 (1997) 95-101
29. Chan M.S., Srividya A., and Norman R.A. Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am. J. Trop. Med. Hyg. 59 (1998) 606-614
30. Ravindran B., Satapathy A.K., Sahoo P.K., and Mohanty M.C. Protective immunity in human filariasis: problems and prospects. Med. Microbiol. Immunol. 192 (2003) 41-46
31. Ravindran B. Natural history of human filariasis - the elusive road. In: Klei T.R., and Rajan T.V. (Eds). The Filaria, World Class Parasites (2002), Kluwer Academic Publishers Group, The Netherlands 87-96
32. Meyrowitsch D.W., Simonsen P., and Magesa S.M. A 26-year follow-up of bancroftian filariasis in two communities in north-eastern Tanzania. Ann. Trop. Med. Parasitol. 98 (2004) 155-169
33. Mohanty S., Ravichandran M., Raman U., Jayaraman K., Kumar swamy V., and Natman T.B. Regulation of parasite antigen-driven immune responses by interleukin-10 and IL-12 in lymphatic filariasis. Infect. Immun. 65 (1997) 1742-1747
34. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum C.O., and Willis C.R. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160 (1998) 943-952
35. Stark G.L., Dickinson A.M., Jackson G.H., Taylor P.R., Proctor S.J., and Middleton P.G. Tumor necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with Graft-verse-host disease after sibling allogenic bone marrow transplantation. Transplantation 76 (2003) 1742-1749
36. Babu S., Blauvelt C.P., Kumaraswami V., and Nutman T.B. Chemokine receptors of T cells and of B cells in lymphatic filarial infection: A role for CCR9 in pathogenesis. J. Infect. Dis. 191 (2005) 1018-1025
37. Esterre P., Plichart C., Huin-Blondey M.O., and Nguyen L.N. Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status. Parasite Immunol. 27 (2005) 9-16
38. Turner P.F., Rockett K.A., Ottesen E.A., Francis H., Awadzi K., and Clark I.A. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. J. Infect. Dis. 169 (1994) 1071-1075